Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma

Ari Adamy, Kian Tai Chong, Daher Chade, James Costaras, Grace Russo, Matthew G. Kaag, Melanie Bernstein, Robert J. Motzer, Paul Russo

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Purpose We analyzed characteristics in patients with recurrent renal cell carcinoma 5 years or later after nephrectomy and determined predictors of survival after recurrence. Materials and Methods From July 1989 to October 2008 at total of 2,368 nephrectomies were done for clinically localized, unilateral renal cell carcinoma at our institution. Of 256 patients with disease recurrence 44 had recurrence 5 years or more after nephrectomy. We compared clinicopathological characteristics in patients with disease recurrence before vs after 5 years. Survival from time of recurrence was assessed based on Memorial Sloan-Kettering Cancer Center risk score, symptoms at recurrence, metastasectomy, tumor diameter, and recurrence stage and site. Results Patients with late recurrence tended to have fewer symptoms at presentation, smaller tumors (median 8.5 vs 7 cm) and less aggressive disease (pT1 in 18% vs 39%). Median overall survival was 6.1 years from time of recurrence. Five-year actuarial survival was 85% in 28 patients at favorable risk and 14% in 10 at intermediate risk (log rank p <0.001). The 5-year estimated overall survival rate was 72% in 31 patients with incidentally detected recurrence and 39% in 11 with symptoms at recurrence (log rank p = 0.01). Conclusions Data suggest that patients with cancer recurrence 5 years after nephrectomy are at favorable risk and have long-term median survival. A favorable Memorial Sloan-Kettering Cancer Center risk score and absent symptoms related to metastasis are associated with longer survival in these patients.

Original languageEnglish (US)
Pages (from-to)433-438
Number of pages6
JournalJournal of Urology
Volume185
Issue number2
DOIs
StatePublished - Feb 1 2011

Fingerprint

Nephrectomy
Renal Cell Carcinoma
Recurrence
Survival
Neoplasms
Metastasectomy
Survival Rate
Neoplasm Metastasis

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Adamy, Ari ; Chong, Kian Tai ; Chade, Daher ; Costaras, James ; Russo, Grace ; Kaag, Matthew G. ; Bernstein, Melanie ; Motzer, Robert J. ; Russo, Paul. / Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma. In: Journal of Urology. 2011 ; Vol. 185, No. 2. pp. 433-438.
@article{5b0d735238de41899c4f6405941ccf85,
title = "Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma",
abstract = "Purpose We analyzed characteristics in patients with recurrent renal cell carcinoma 5 years or later after nephrectomy and determined predictors of survival after recurrence. Materials and Methods From July 1989 to October 2008 at total of 2,368 nephrectomies were done for clinically localized, unilateral renal cell carcinoma at our institution. Of 256 patients with disease recurrence 44 had recurrence 5 years or more after nephrectomy. We compared clinicopathological characteristics in patients with disease recurrence before vs after 5 years. Survival from time of recurrence was assessed based on Memorial Sloan-Kettering Cancer Center risk score, symptoms at recurrence, metastasectomy, tumor diameter, and recurrence stage and site. Results Patients with late recurrence tended to have fewer symptoms at presentation, smaller tumors (median 8.5 vs 7 cm) and less aggressive disease (pT1 in 18{\%} vs 39{\%}). Median overall survival was 6.1 years from time of recurrence. Five-year actuarial survival was 85{\%} in 28 patients at favorable risk and 14{\%} in 10 at intermediate risk (log rank p <0.001). The 5-year estimated overall survival rate was 72{\%} in 31 patients with incidentally detected recurrence and 39{\%} in 11 with symptoms at recurrence (log rank p = 0.01). Conclusions Data suggest that patients with cancer recurrence 5 years after nephrectomy are at favorable risk and have long-term median survival. A favorable Memorial Sloan-Kettering Cancer Center risk score and absent symptoms related to metastasis are associated with longer survival in these patients.",
author = "Ari Adamy and Chong, {Kian Tai} and Daher Chade and James Costaras and Grace Russo and Kaag, {Matthew G.} and Melanie Bernstein and Motzer, {Robert J.} and Paul Russo",
year = "2011",
month = "2",
day = "1",
doi = "10.1016/j.juro.2010.09.100",
language = "English (US)",
volume = "185",
pages = "433--438",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

Adamy, A, Chong, KT, Chade, D, Costaras, J, Russo, G, Kaag, MG, Bernstein, M, Motzer, RJ & Russo, P 2011, 'Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma', Journal of Urology, vol. 185, no. 2, pp. 433-438. https://doi.org/10.1016/j.juro.2010.09.100

Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma. / Adamy, Ari; Chong, Kian Tai; Chade, Daher; Costaras, James; Russo, Grace; Kaag, Matthew G.; Bernstein, Melanie; Motzer, Robert J.; Russo, Paul.

In: Journal of Urology, Vol. 185, No. 2, 01.02.2011, p. 433-438.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma

AU - Adamy, Ari

AU - Chong, Kian Tai

AU - Chade, Daher

AU - Costaras, James

AU - Russo, Grace

AU - Kaag, Matthew G.

AU - Bernstein, Melanie

AU - Motzer, Robert J.

AU - Russo, Paul

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Purpose We analyzed characteristics in patients with recurrent renal cell carcinoma 5 years or later after nephrectomy and determined predictors of survival after recurrence. Materials and Methods From July 1989 to October 2008 at total of 2,368 nephrectomies were done for clinically localized, unilateral renal cell carcinoma at our institution. Of 256 patients with disease recurrence 44 had recurrence 5 years or more after nephrectomy. We compared clinicopathological characteristics in patients with disease recurrence before vs after 5 years. Survival from time of recurrence was assessed based on Memorial Sloan-Kettering Cancer Center risk score, symptoms at recurrence, metastasectomy, tumor diameter, and recurrence stage and site. Results Patients with late recurrence tended to have fewer symptoms at presentation, smaller tumors (median 8.5 vs 7 cm) and less aggressive disease (pT1 in 18% vs 39%). Median overall survival was 6.1 years from time of recurrence. Five-year actuarial survival was 85% in 28 patients at favorable risk and 14% in 10 at intermediate risk (log rank p <0.001). The 5-year estimated overall survival rate was 72% in 31 patients with incidentally detected recurrence and 39% in 11 with symptoms at recurrence (log rank p = 0.01). Conclusions Data suggest that patients with cancer recurrence 5 years after nephrectomy are at favorable risk and have long-term median survival. A favorable Memorial Sloan-Kettering Cancer Center risk score and absent symptoms related to metastasis are associated with longer survival in these patients.

AB - Purpose We analyzed characteristics in patients with recurrent renal cell carcinoma 5 years or later after nephrectomy and determined predictors of survival after recurrence. Materials and Methods From July 1989 to October 2008 at total of 2,368 nephrectomies were done for clinically localized, unilateral renal cell carcinoma at our institution. Of 256 patients with disease recurrence 44 had recurrence 5 years or more after nephrectomy. We compared clinicopathological characteristics in patients with disease recurrence before vs after 5 years. Survival from time of recurrence was assessed based on Memorial Sloan-Kettering Cancer Center risk score, symptoms at recurrence, metastasectomy, tumor diameter, and recurrence stage and site. Results Patients with late recurrence tended to have fewer symptoms at presentation, smaller tumors (median 8.5 vs 7 cm) and less aggressive disease (pT1 in 18% vs 39%). Median overall survival was 6.1 years from time of recurrence. Five-year actuarial survival was 85% in 28 patients at favorable risk and 14% in 10 at intermediate risk (log rank p <0.001). The 5-year estimated overall survival rate was 72% in 31 patients with incidentally detected recurrence and 39% in 11 with symptoms at recurrence (log rank p = 0.01). Conclusions Data suggest that patients with cancer recurrence 5 years after nephrectomy are at favorable risk and have long-term median survival. A favorable Memorial Sloan-Kettering Cancer Center risk score and absent symptoms related to metastasis are associated with longer survival in these patients.

UR - http://www.scopus.com/inward/record.url?scp=78651334136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651334136&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2010.09.100

DO - 10.1016/j.juro.2010.09.100

M3 - Article

C2 - 21167521

AN - SCOPUS:78651334136

VL - 185

SP - 433

EP - 438

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -